Pfizer Is Ready To File Vaccine, With More Good News On Over-65s Efficacy

94% Efficacy In Key Older Group

Pfizer is moving swiftly towards an emergency use approval filing, with Moderna not far behind.  

NEW YORK CITY - MAY 2015: Metal plate logo of Pfizer in his headquarters building. Pfizer is an American multinational pharmaceutical corporation, one of the world's largest pharmaceutical companies.
Pfizer and BioNTech will file for an Emergency Use Authorization 'within days' - with Moderna not far behind.

Pfizer and BioNTech have completed the Phase III study of their COVID-19 vaccine, and have declared themselves just “days away” from filing final safety and efficacy data with regulators around the world.

The companies announced their first interim analysis from its Phase III trial of mRNA-based vaccine candidate BNT162b2 on 9 November,...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip